title: Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
abstract: Inflammatory hepatocellular adenomas are benign liver tumours defined by the presence of inflammatory infiltrates and by the increased expression of inflammatory proteins in tumour hepatocytes. Here we show a marked activation of the interleukin (IL)-6 signalling pathway in this tumour type; sequencing candidate genes pinpointed this response to somatic gain-of-function mutations in the IL6ST gene, which encodes the signalling co-receptor gp130. Indeed, 60% of inflammatory hepatocellular adenomas harbour small in-frame deletions that target the binding site of gp130 for IL-6, and expression of four different gp130 mutants in hepatocellular cells activates signal transducer and activator of transcription 3 (STAT3) in the absence of ligand. Furthermore, analysis of hepatocellular carcinomas revealed that rare gp130 alterations are always accompanied by beta-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant conversion of hepatocytes. The recurrent gain-of-function gp130 mutations in these human hepatocellular adenomas fully explains activation of the acute inflammatory phase observed in tumourous hepatocytes, and suggests that similar alterations may occur in other inflammatory epithelial tumours with STAT3 activation.
authors.affiliation: Inserm, U674, Génomique fonctionnelle des tumeurs solides, Paris F-75010, France.
authors.forename: Sandra
authors.initials: S
authors.lastname: Rebouissou
authors.forename: Mohamed
authors.initials: M
authors.lastname: Amessou
authors.forename: Gabrielle
authors.initials: G
authors.lastname: Couchy
authors.forename: Karine
authors.initials: K
authors.lastname: Poussin
authors.forename: Sandrine
authors.initials: S
authors.lastname: Imbeaud
authors.forename: Camilla
authors.initials: C
authors.lastname: Pilati
authors.forename: Tina
authors.initials: T
authors.lastname: Izard
authors.forename: Charles
authors.initials: C
authors.lastname: Balabaud
authors.forename: Paulette
authors.initials: P
authors.lastname: Bioulac-Sage
authors.forename: Jessica
authors.initials: J
authors.lastname: Zucman-Rossi
mesh_terms: D018248:Adenoma, Liver Cell / Q000235:genetics* / Q000473:pathology*; D045744:Cell Line, Tumor; D050822:Cytokine Receptor gp130 / Q000235:genetics* / Q000378:metabolism*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007249:Inflammation / Q000235:genetics / Q000473:pathology; D007372:Interferons / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism; D017384:Sequence Deletion / Q000235:genetics*; D015398:Signal Transduction
chemical_list: C494199:IL6ST protein, human; D015850:Interleukin-6; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D050822:Cytokine Receptor gp130; D007372:Interferons